Get Easy Health Digest™ in your inbox and don’t miss a thing when you subscribe today. Plus, get the free bonus report, Mother Nature’s Tips, Tricks and Remedies for Cholesterol, Blood Pressure & Blood Sugar as my way of saying welcome to the community!
Previously, I explained the important differences between synthetic and real estrogens and progesterone, including the research showing the benefits of the real, natural hormones (information that is still being ignored by mainstream doctors).
Women who take hormones should be taking natural progesterone with or without natural estrogen. You also need to know what happens when estrogen becomes dominant relative to progesterone levels.
When you start to reach menopause, progesterone levels usually drop even before estrogen levels. Low progesterone levels cause the classic symptoms of premenstrual syndrome (PMS). These include irregular, heavy or painful periods; breast tenderness; mood swings; irritability; insomnia; migraine headaches; and bloating (puffy face and extremities). Therefore, progesterone supplementation becomes very useful for many women even before menopause.
In the body, progesterone is primarily manufactured in the adrenal glands and ovaries, though some is produced in the brain.
What does progesterone do for women? First of all, progesterone regulates your menstrual cycle and prepares your uterus for gestation: We know that pregnancy requires high levels of it for gestation to occur. Progesterone is calming and provides for restful sleep. Most notably, it prevents the symptoms of PMS.
Reasons For Natural Progesterone
In addition to treating PMS symptoms, progesterone supplementation during or near the menopause years acts much like estrogen in treating menopausal symptoms (hot flashes, breast tenderness, decreased sex drive, vaginal dryness, irregular periods and even urinary leakage or urgency). A one-year trial of bio-identical transdermal progesterone cream in postmenopausal women produced a significant reduction in hot flashes, according to a 1999 report in Obstetrics and Gynecology.  But it has important long-term health effects, too.
While the media successfully portrayed synthetic progestin and/or oral estrogen as harmful for long-term use (which they are), they failed to proclaim the health benefits of long term bio-identical progesterone and transdermal (e.g. topical cream) estrogen. These benefits include protection from uterine and breast cancers, lowering your heart disease risk (one of many ways to do this) and reducing osteoporosis (only one of many ways to do this, too).
Progesterone Lowers Breast And Uterine Cancer Risk
A long list of studies have taught us that natural progesterone helps reduce breast cancer:
- In 1981, the Journal of Epidemiology  reported that 1,083 women were treated for infertility and followed for 13 to 33 years for incidence of breast cancer. The premenopausal risk for breast cancer was 5.4 times higher in women with low progesterone levels compared to those with normal levels, and there were 10 times more deaths from cancer in the low progesterone group compared with those with normal progesterone levels.
- A 2002 study reported in Cancer Epidemiology, Biomarkers & Prevention  showed in a case-control study looking at third-trimester progesterone levels and breast cancer risk that increasing levels of progesterone were associated with decreased risk of breast cancer. This association was strongest before the age of 50. They also found that those in the highest quartile of progesterone levels had a 50 percent reduction in breast cancer compared with those in the lowest quartile of progesterone levels.
- In 2003, researchers found that transdermal or vaginal progesterone cream for four weeks reduced uterine lining thickening caused by an estrogen drug in postmenopausal women. 
- In 2004, a prospective study of progesterone levels and associated breast cancer risk in 5,963 women was reported in the International Journal of Cancer. 
- In 2008, researchers reported that they had followed 80,000 postmenopausal women for more than eight years. They showed that using natural progesterone along with estrogen significantly reduced breast cancer risk compared to the use of synthetic progestin. 
Progesterone Improves Heart Health
Progesterone also is beneficial to heart health. It has a vascular relaxation effect (to lower blood pressure and the strain on the heart). The Women’s Health Initiative studies showed that progesterone (unlike synthetic progestins) increases the cardio-protective effects of estrogen and reduces the risk of heart attack and stroke. Progesterone also improves lipid profiles and helps estrogen to improve lipid profiles (unlike synthetic progestins). There are several similar studies to show this beneficial heart health effect from natural progesterone.
Progesterone’s Effect On Bone Strength
Scientists have observed that natural progesterone stimulates osteoblast activity (new bone formation) and helps prevent osteoporosis.  Estrogen does, too. And when added together, progesterone and estrogen collaborate for maximal prevention of bone loss. 
The other contributors to bone loss are poor eating habits, vitamin and mineral deficiencies, and lack of exercise.
Bio-Identical Transdermal Estrogen
Natural estrogen (cream, not pills) replacement simply works better than synthetic estrogen pills do for reducing menopausal symptoms. A study using estriol therapy that was reported in the November 1987 Hormone and Metabolic Research  showed that it reduced menopausal symptoms in 92 percent of subjects and completely elimination hot flashes and sweating in 71 percent of the subjects. It completely eliminated depressed moods in 24 percent, and depressed moods were reduced in severity for another 33 percent. It also reduced headaches by two-thirds, and skin improved in some of the subjects. And there were no significant side effects reported.
Transdermal (topical) bio-identical estrogen does more than just control menopausal symptoms of estrogen deficiency. It provides these longer-term health benefits, too: prevention of memory loss, heart health, and improved sexual desire and functions. Added to progesterone, it also reduces breast cancer risk and strengthens bones, as mentioned above.
Estrogen For Better Memory
Animal and human studies show that transdermal estrogen replacement therapy, when started before menopause, decreases memory loss in older age.  In the Italian Longitudinal Study on Aging reported in 1998, researchers found that among the 2,816 women aged 65 to 84 years who were followed, the rate of Alzheimer’s disease was only one-fourth as much among estrogen users compared with the general female population of the same age and multiple other risk factors. 
A study reported in 1996 found that that among 156 women who reported taking estrogen after onset of menopause, those who later developed Alzheimer’s disease did so much later (delayed onset) and significantly less (60 percent fewer) compared with women who did not take estrogen. Also, those who had used estrogen longer than a year had even a greater risk reduction for Alzheimer’s disease. 
We know that transdermal estrogen lowers bad cholesterol (LDL) and raises good cholesterol (HDL). Coronary artery spasm, which precipitates a heart attack by squeezing down areas of the vessel where there is already atherosclerotic plaque, is decreased with the use of estrogen and also estrogen plus progesterone.  Estrogen lowers anti-thrombin III levels, thereby lowering recurrent venous thrombosis (vein clotting).
It is clearly known that transdermal estrogen supplementation reduces bone fracture rates in postmenopausal women. Subjects using only a low dose of only 0.1 mg per day stopped losing bone density and dramatically reduced their fracture rate as demonstrated in two clinical trials.  
Estrogen plus progesterone clearly decreases breast cancer risk. This was shown to be true in a double blind placebo-controlled trial  of women given estrogen plus progesterone prior to breast surgery reported in 1995. This was shown to be true in a randomized double-blind study  reported in 1998 and also in a primate animal study  reported in 2007.
Estrogen dominance occurs often because progesterone levels drop sooner and more dramatically than estrogen levels do, thus leaving estrogen levels too high relative to progesterone. The symptoms of estrogen dominance includeanxiety, breast tenderness, headaches, allergies, fatigue, weight gain and more. This is largely due to progesterone deficiency, a poor diet, a consistently stressful lifestyle (high cortisol levels reduces progesterone), or exposure to hormone mimics (called xenoestrogens) from food, personal hygiene products, medications and plastics.
The health effects of natural transdermal estrogen and progesterone (oral or transdermal) supplementation are very different than the synthetic hormone versions often promoted by mainstream doctors.
In my next article I’ll briefly discuss the best lab tests available to check your hormone levels. If indeed your levels are off, there are several treatment options I recommend even before hormone replacement. I’ll discuss these dietary, lifestyle, herbal and nutrient supplement options; and I’ll show some example cases to illustrate how estrogen and progesterone replacement fit in to make all the difference if your hormones are low or out of balance.
To feeling good in life,
Michael Cutler, M.D.
Easy Health Options
 Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol. 1999 Aug;94(2):225-8.
 Cowan LD, et al. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 1981;114(2)209-217.
 Peck JD, Huka BS, Poole C, et al. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 2002;11(4):361-368.
 Leonetti HB, Wilson KJ, Anasti JN. Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. Fertil Steril. 2003 Jan;79(1):221-2.
 Micheli A, Muti P, Secreto G, et al. Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 2004;112(2):312-318.
 Fournier A, Berrino F, Clave-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008;107(1):103-111.
 Heersche JN, Bellows CG, Ishida Y. The decrease in bone mass associated with aging and menopause. J Prosthet Dent. 1998 Jan;79(1):14-6.
 Seifert-Klauss V, Prior JC. Progesterone and bone: actions promoting bone health in women. J Osteoporos. 2010 Oct 31;2010:845180.
 Lauritzen C. Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints. Horm Metab Res. 1987 Nov;19(11):579-84.
 Craig MC, Murphy DG. Estrogen therapy and Alzheimer’s dementia. Ann N Y Acad Sci. 2010 Sep;1205:245-53
 Baldereshi M, Di Carlo A, et al. Estrogen-replacement therapy and Alzheimer’s disease in the Italian Longitudinal Study on Aging. Neurology 1998 Apr;50(4):996-1002.
 Tang MX. Jacobs D, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 1996 Aug17;348(9025):429-32.
 Minshall RD, et al. Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys. J Clin Endocrinol Metab 1998;83(2):649-659.
 Lufkin EG, Wahner HW, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117(1):1-9.
 Cicinelli E, Galantino P, et al. Bone metabolism changes after transdermal estradiol dose reduction during estrogen replacement therapy: A 1-year prospective study. Maturitas 1994;19(3):133-139.
 Chang KJ, et al. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 1995;63(4):785-791.
 Foidart JM, et al. Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 1998;69(5):963-969.
 Wood CE, et al. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast Cancer Res Treat 2007;101(2):125-134.